FDA Warned Millipore on H1N1 Test Marketing | GenomeWeb

By a GenomeWeb staff reporter

This article has been updated to include comments from a Millipore spokesperson.

NEW YORK (GenomeWeb News) – The US Food and Drug Administration disclosed on its website Tuesday that it had sent a warning letter to Millipore in September regarding the firm's promotional materials for influenza diagnostics products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."